BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31099910)

  • 1. Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.
    Vlot MC; Wiepjes CM; de Jongh RT; T'Sjoen G; Heijboer AC; den Heijer M
    J Bone Miner Res; 2019 Oct; 34(10):1862-1872. PubMed ID: 31099910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
    Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
    Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen.
    Wiepjes CM; de Jongh RT; de Blok CJ; Vlot MC; Lips P; Twisk JW; den Heijer M
    J Bone Miner Res; 2019 Mar; 34(3):447-454. PubMed ID: 30537188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
    Dobrolińska M; van der Tuuk K; Vink P; van den Berg M; Schuringa A; Monroy-Gonzalez AG; García DV; Schultz WCMW; Slart RHJA
    J Sex Med; 2019 Sep; 16(9):1469-1477. PubMed ID: 31326306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.
    Wiepjes CM; Vlot MC; Klaver M; Nota NM; de Blok CJ; de Jongh RT; Lips P; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
    J Bone Miner Res; 2017 Jun; 32(6):1252-1260. PubMed ID: 28370342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of the Long-Term Effects of Transgender Hormone Therapy on Bone Markers and Bone Mineral Density and Their Potential Effects in Implant Therapy.
    Delgado-Ruiz R; Swanson P; Romanos G
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31159456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-Affirming Hormone Treatment Induces Facial Feminization in Transwomen and Masculinization in Transmen: Quantification by 3D Scanning and Patient-Reported Outcome Measures.
    Tebbens M; Nota NM; Liberton NPTJ; Meijer BA; Kreukels BPC; Forouzanfar T; Verdaasdonk RM; den Heijer M
    J Sex Med; 2019 May; 16(5):746-754. PubMed ID: 30926514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People.
    Chen H; Wiepjes CM; van Schoor NM; Heijboer AC; de Jongh RT; den Heijer M; Lips P
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2728-2734. PubMed ID: 30785996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in grip strength in trans people and its association with lean body mass and bone density.
    Scharff M; Wiepjes CM; Klaver M; Schreiner T; T'Sjoen G; den Heijer M
    Endocr Connect; 2019 Jul; 8(7):1020-1028. PubMed ID: 31247588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
    Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
    J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
    Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
    J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.
    van Velzen DM; Nota NM; Simsek S; Conemans EB; T'Sjoen G; den Heijer M
    Eur J Endocrinol; 2020 Nov; 183(5):529-536. PubMed ID: 33071222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.
    Tsai JN; Burnett-Bowie SM; Lee H; Leder BZ
    Bone; 2017 Feb; 95():20-25. PubMed ID: 27840301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
    Ristori J; Cocchetti C; Castellini G; Pierdominici M; Cipriani A; Testi D; Gavazzi G; Mazzoli F; Mosconi M; Meriggiola MC; Cassioli E; Vignozzi L; Ricca V; Maggi M; Fisher AD
    J Sex Med; 2020 Jan; 17(1):142-151. PubMed ID: 31735612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
    van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
    JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
    JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.